Back to search

Article

Safety of Roxadustat Combined with Epoetin Alfa in Hemodialysis Patients with Anemia: A Cohort Study

2022-11-23

Abstract excerpt

<h4>Background: </h4> Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis 1 , China was the first country in the world to complete phase III clinical trials and was officially approved for marketing in 2018 2 . Recombinant human erythropoietin(rhEPO) is a traditional exogenous supplement of erythropoietin for the treatment of renal anemia.Due to a lack of rese...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16d854df-8777-51fe-ba9a-7291cb2ff7e5
DOI
10.21203/rs.3.rs-2222877/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety of Roxadustat Combined with Epoetin Alfa in Hemodialysis Patients with Anemia: A Cohort StudyDOI 10.21203/rs.3.rs-2222877/v1
Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach in management of Anemia of Chronic Kidney DiseaseSemantic proximity
Clinical efficacy of sacubitril/valsartan in maintenance hemodialysis patients with HFpEFSemantic proximity
Are patients on chronic hemodialysis treatment protected against mortality due to COVID-19? A single-center retrospective cohort of patients hospitalized with COVID-19 requiring hemodialysis treatmentSemantic proximity
Challenging patient phenotypes in the management of anaemia of chronic kidney disease.Semantic proximity
Safety and Efficacy of Nirmatrelvir/Ritonavir in Advanced Kidney DiseaseSemantic proximity
Research on the Development of an Intelligent Prediction Model for Blood Pressure Variability During HemodialysisSemantic proximity
Real World Use of Pegylated Erythropoietin in CKD Anemia: An Indian Modified Delphi ConsensusSemantic proximity
COVID-19 vaccination trends and side effects among Egyptian hemodialysis patients: a multicenter survey studySemantic proximity
Treatment of Essential Thrombocythemia with Anagrelide Is Associated with an Increased Risk of Worsened Kidney Function.Semantic proximity
Alteration of the DNA Methylation Signature of Renal Erythropoietin-Producing Cells Governs the Sensitivity to Drugs Targeting the Hypoxia-Response Pathway in Kidney Disease ProgressionSemantic proximity
Clinical Features of Hemodialysis (HD) patients confirmed with Coronavirus Disease 2019 (COVID-19): a Retrospective Case-Control StudySemantic proximity
Incidence, risk factors and prognosis of acute kidney injury in patients treated with immune checkpoint inhibitors: A retrospective studySemantic proximity
Select a neighboring publication to make it the new centre.